WENONA DOTSON: Open Payments
NPI 1154637288 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 17 payments from 10 companies in 2025. Trend: 2023 $454 · 2024 $246 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $95 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 1 | $19 |
| Organon LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| CeQur Corporation | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: QULIPTA, Auvelity, REXULTI, VRAYLAR, CAPLYTA, ZEPBOUND, NEXPLANON, Mirena.
Industry payments across TN — which companies pay providers there.
